Cargando…
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
BACKGROUND: People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) experience a wide range of clinical manifestations, from asymptomatic and mild illness to severe illness and death, influenced by age and a variety of comorbidities. Neutralizing antibodies (nAbs) are thoug...
Autores principales: | Karuna, Shelly, Li, Shuying Sue, Grant, Shannon, Walsh, Stephen R., Frank, Ian, Casapia, Martin, Trahey, Meg, Hyrien, Ollivier, Fisher, Leigh, Miner, Maurine D., Randhawa, April K., Polakowski, Laura, Kublin, James G., Corey, Lawrence, Montefiori, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687542/ https://www.ncbi.nlm.nih.gov/pubmed/34871308 http://dx.doi.org/10.1371/journal.pmed.1003868 |
Ejemplares similares
-
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region
por: Karuna, Shelly, et al.
Publicado: (2023) -
Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19
por: Schuster, Daniel J., et al.
Publicado: (2022) -
Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021) -
Accelerating clinical trial development in vaccinology: COVID-19 and beyond
por: Corey, Lawrence, et al.
Publicado: (2022) -
Transport vesicle uncoating: it’s later than you think
por: Trahey, Meg, et al.
Publicado: (2010)